U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07431944) titled 'Silencing Neuroma Pain-Botulinum Toxin Versus Local Anesthetic Injection' on Feb. 14.
Brief Summary: Neuroma-related pain is a frequent and disabling condition after limb trauma and amputation. Available treatments often provide short-lasting or insufficient analgesia. The SILENCE-NEUROMA Trial is a multicenter, randomized, double-blind, active-controlled study designed to compare the efficacy and safety of botulinum toxin type A versus local anesthetic injection for the treatment of neuroma-related pain. The primary outcome is pain reduction at 8 weeks after treatment.
Study Start Date: Feb. 15
Study Type: INTERVENTIONAL
Conditi...